Article
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
The pharmacogenomics journal - 1 Apr 2014
Bluett J, Ibrahim I, Plant D, Hyrich K L, Morgan A W, Wilson A G, Isaacs J D, Barton A
Abstract excerpt
Eligibility for anti-tumour necrosis factor (TNF) therapy in most European countries is restricted to severe, active rheumatoid arthritis (RA). The DAS28 score is a marker of disease severity and incorporates one of two inflammatory markers, erythrocyte sedimentation rate (ESR) or C-reactive prot...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.